Tag: Rare disease patient journey mapping
Gene Therapy Budgeting, Orphan Drug Pricing, Patient Journey Mapping & Viral Vector CDMO Selection: A Comprehensive Guide
In the rapidly evolving realm of gene therapy, effective budgeting, pricing, patient care, and CDMO selection are crucial. According to a 2023 study by Wong et al., annual US spending on gene therapies could reach $20.4 billion. The American Medical Association and the Centers for Medicare & Medicaid Services also offer valuable insights on this